EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nuclear Cardiology Surrogate Biomarkers in Clinical Trials

Robert J H Miller, Krishna K Patel, Jacek Kwiecinski, Leandro Slipczuk, Marc Dweck, David E Newby, Panithaya Chareonthaitawee, Piotr Slomka

Journal of Nuclear Medicine · 2025

DOI: 10.2967/jnumed.124.267869 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Nuclear Medicine, 2025. Verfasst von Robert J H Miller und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles…. Hauptthemen laut MEDLINE: Biomarkers, Clinical Trials as Topic, Nuclear Medicine, Cardiology. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nuclear cardiology offers a diverse range of imaging tools that provide valuable insights into myocardial perfusion, inflammation, metabolism, neuroregulation, thrombosis, and microcalcification. These techniques are crucial not only for diagnosing and managing cardiovascular conditions but also for gaining pathophysiologic insights. Surrogate biomarkers in nuclear cardiology, represented by detectable imaging changes, correlate with disease processes or therapeutic responses and can serve as endpoints in clinical trials when they demonstrate a clear link with these processes. By providing early indicators of therapeutic efficacy-often before clinical outcomes manifest-surrogate biomarkers can accelerate treatment development. This disease-focused review will highlight key nuclear cardiology surrogate biomarkers, emphasizing the importance of standardized imaging protocols and robust quantitative techniques to ensure accuracy and reproducibility. We will also explore the challenges to the broader adoption of imaging biomarkers, including the need for well-defined pathophysiologic correlations, greater data diversity in clinical research, and overcoming regulatory barriers. Addressing these challenges will improve the utility of imaging biomarkers in clinical trials, enabling more precise cardiovascular care through early diagnosis and therapeutic monitoring, ultimately accelerating the development of novel cardiovascular therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersClinical Trials as TopicNuclear MedicineCardiologyHumans

Stichwörter der Autor:innen

PETPET/CTSPECTbiomarkercardiology (clinical)nuclear cardiology

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging, and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California.
  • Department of Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada.
  • Department of Medicine (Cardiology) and Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland.
  • Cardiology Division, Montefiore Medical Center, Bronx, New York.
  • British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; and.

Förderung

  • British Heart Foundation

Zitieren

APA

Miller, R. J. H., Patel, K. K., Kwiecinski, J., Slipczuk, L., Dweck, M., Newby, D. E., Chareonthaitawee, P., & Slomka, P. (2025). Nuclear Cardiology Surrogate Biomarkers in Clinical Trials. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.267869

Vancouver

Miller RJH, Patel KK, Kwiecinski J, Slipczuk L, Dweck M, Newby DE, et al. Nuclear Cardiology Surrogate Biomarkers in Clinical Trials. Journal of Nuclear Medicine. 2025. doi:10.2967/jnumed.124.267869

BibTeX
@article{Miller2025,
  author = {Miller, Robert J H and Patel, Krishna K and Kwiecinski, Jacek and Slipczuk, Leandro and Dweck, Marc and Newby, David E and Chareonthaitawee, Panithaya and Slomka, Piotr},
  title = {Nuclear Cardiology Surrogate Biomarkers in Clinical Trials},
  journal = {Journal of Nuclear Medicine},
  year = {2025},
  doi = {10.2967/jnumed.124.267869}
}
Kostenlos starten →